The Woodlands, Texas — According to state and local economic development sources Cellipont Bioservices plans to invest $32,000,000.00 to build out 75,140 square feet of new space in The Woodlands. The company plans to occupy the new space at 9501 Lakeside Blvd. in The Woodlands, on or about January 1, 2024. According to the company website Cellipont Bioservices is a cell therapy CDMO with more than 15 years experience in the development and small-to-large batch manufacturing of cell therapies. Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients to expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities. We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont Bioservices has very deep technical experience, including 18,000+ tissue samples and more than 900 primary cell cultures. With decades of experience at advanced therapy service companies large and small, our leadership team is guiding Celliponts growth with deep knowledge of what it takes succeed in this space. Cellipont Bioservices facilities and quality systems are GMP-compliant and we hold a California Food & Drug Branch manufacturing license. We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches.

To learn more about Cellipont Bioservices, visit http://cellipont.com/

Company Contact:
Deborah Wild, President and Chief Executive Officer
dwild@cellipont.com
https://www.linkedin.com/in/deborahwild/
858-218-8670

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved